The International Clinical Respiratory Group * * Participants at the second meeting were: Roger C. Bone, M.D., F.C.C.P., Department of Internal Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA; Peter Calverley, F.R.C.P., F.C.C.P., Fazakerley Hospital and the University Department of Medicine, Liverpool, United Kingdom; Kenneth R. Chapman, M.D., F.C.C.P., Acting Director, Asthma Centre, Toronto Hospital, Toronto, Canada; Ronald Dahl, M.D., Aarhus Kommune Hospital, Aarhus, Denmark; Nicholas Gross, M.D., Department of Pulmonary Diseases, Stritch School of Medicine, Loyola University, Chicago, USA; Helgo Magnussen, M.D., Zentrum für Pneumologie und Thoraxchirurgie, LVA-Freie und Hansestadt Hamburg, Grosshansdorf, Germany; André P. Perruchoud, M.D., F.C.C.P., Division of Pulmonary Diseases, Universitätsklinik, Basel, Switzerland; and Anthony Rebuck, M.D., Asthma Centre, Toronto Hospital, Toronto, Canada. Report of the Second Meeting
Titel:
The International Clinical Respiratory Group * * Participants at the second meeting were: Roger C. Bone, M.D., F.C.C.P., Department of Internal Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA; Peter Calverley, F.R.C.P., F.C.C.P., Fazakerley Hospital and the University Department of Medicine, Liverpool, United Kingdom; Kenneth R. Chapman, M.D., F.C.C.P., Acting Director, Asthma Centre, Toronto Hospital, Toronto, Canada; Ronald Dahl, M.D., Aarhus Kommune Hospital, Aarhus, Denmark; Nicholas Gross, M.D., Department of Pulmonary Diseases, Stritch School of Medicine, Loyola University, Chicago, USA; Helgo Magnussen, M.D., Zentrum für Pneumologie und Thoraxchirurgie, LVA-Freie und Hansestadt Hamburg, Grosshansdorf, Germany; André P. Perruchoud, M.D., F.C.C.P., Division of Pulmonary Diseases, Universitätsklinik, Basel, Switzerland; and Anthony Rebuck, M.D., Asthma Centre, Toronto Hospital, Toronto, Canada. Report of the Second Meeting